208 related articles for article (PubMed ID: 11459208)
21. Thymidine rescue: an antidote for pemetrexed-related toxicity in the setting of acute renal failure.
Castro M
J Clin Oncol; 2003 Nov; 21(21):4066. PubMed ID: 14581433
[No Abstract] [Full Text] [Related]
22. Cytokinetic comparison of thymidine and leucovorin rescue of marrow in humans after exposure to high-dose methotrexate.
Howell SB; Krishan A; Frei E
Cancer Res; 1979 Apr; 39(4):1315-20. PubMed ID: 311245
[TBL] [Abstract][Full Text] [Related]
23. A single center retrospective analysis of a protocol for high-dose methotrexate and leucovorin rescue administration.
Cerminara Z; Duffy A; Nishioka J; Trovato J; Gilmore S
J Oncol Pharm Pract; 2019 Jan; 25(1):76-84. PubMed ID: 28942720
[TBL] [Abstract][Full Text] [Related]
24. Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma.
Pitman SW; Frei E
Cancer Treat Rep; 1977 Jul; 61(4):695-701. PubMed ID: 18282
[TBL] [Abstract][Full Text] [Related]
25. 5-fluorouracil modulates the toxicity of high dose methotrexate.
White RM
J Clin Pharmacol; 1995 Dec; 35(12):1156-65. PubMed ID: 8750366
[TBL] [Abstract][Full Text] [Related]
26. Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance.
Ramsey LB; Balis FM; O'Brien MM; Schmiegelow K; Pauley JL; Bleyer A; Widemann BC; Askenazi D; Bergeron S; Shirali A; Schwartz S; Vinks AA; Heldrup J
Oncologist; 2018 Jan; 23(1):52-61. PubMed ID: 29079637
[TBL] [Abstract][Full Text] [Related]
27. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
Joannon P; Oviedo I; Campbell M; Tordecilla J
Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
[TBL] [Abstract][Full Text] [Related]
28. [Acute toxicity of high doses of methotrexate in treatment of ALL in children: a case study].
Periáñez-Párraga L; Pérez-Rodríguez O; do Pazo-Oubiña F; Crespí-Monjo M
Farm Hosp; 2009; 33(3):172-3. PubMed ID: 19712601
[No Abstract] [Full Text] [Related]
29. [High dose methotrexate with leucovorin rescue in the treatment of malignant lymphoma].
Sampi K; Hattori M
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1068-73. PubMed ID: 6985194
[TBL] [Abstract][Full Text] [Related]
30. Effect of charcoal hemoperfusion for removal of plasma methotrexate in a patient with acute renal failure.
Nemoto T; Imai C; Kaneko U; Takachi T; Iwabuchi H; Tanaka A; Nakamura G; Ogose A; Uchiyama M
Pediatr Hematol Oncol; 2009; 26(7):520-5. PubMed ID: 19863208
[TBL] [Abstract][Full Text] [Related]
31. Sequential use of hemoperfusion and single-pass albumin dialysis can safely reverse methotrexate nephrotoxicity.
Chan WK; Hui WF
Pediatr Nephrol; 2016 Oct; 31(10):1699-703. PubMed ID: 27335061
[TBL] [Abstract][Full Text] [Related]
32. [Renal toxicity of high-dose methotrexate].
Garcia H; Leblond V; Goldwasser F; Bouscary D; Raffoux E; Boissel N; Broutin S; Joly D
Nephrol Ther; 2018 Apr; 14 Suppl 1():S103-S113. PubMed ID: 29606256
[TBL] [Abstract][Full Text] [Related]
33. Resumption of high-dose methotrexate after methotrexate-induced nephrotoxicity and carboxypeptidase G2 use.
Snyder RL
Am J Health Syst Pharm; 2007 Jun; 64(11):1163-9. PubMed ID: 17519458
[TBL] [Abstract][Full Text] [Related]
34. Modulation versus rescue of antimetabolite toxicity by salvage metabolites administered by continuous infusion.
Grindey GB; Semon JH; Pavelic ZP
Antibiot Chemother (1971); 1978; 23():295-304. PubMed ID: 306219
[TBL] [Abstract][Full Text] [Related]
35. High-dose leucovorin as sole therapy for methotrexate toxicity.
Flombaum CD; Meyers PA
J Clin Oncol; 1999 May; 17(5):1589-94. PubMed ID: 10334548
[TBL] [Abstract][Full Text] [Related]
36. Case files of the New York City Poison Control Center: antidotal strategies for the management of methotrexate toxicity.
Smith SW; Nelson LS
J Med Toxicol; 2008 Jun; 4(2):132-40. PubMed ID: 18570175
[No Abstract] [Full Text] [Related]
37. [SLCO1B1c. 521T>C gene polymorphisms are associated with high-dose methotrexate pharmacokinetics and clinical outcome of pediatric acute lymphoblastic leukemia].
Zhang H; He X; Li J; Wang Y; Wang C; Chen Y; Niu C; Gao P
Zhonghua Er Ke Za Zhi; 2014 Oct; 52(10):770-6. PubMed ID: 25537545
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
[TBL] [Abstract][Full Text] [Related]
39. Glucarpidase treatment for methotrexate intoxication: a case report and review of the literature.
Boelens AD; Mathôt RAA; Vlaar APJ; Bouman CSC
Neth J Med; 2018 Jan; 76(1):36-39. PubMed ID: 29380731
[TBL] [Abstract][Full Text] [Related]
40. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]